Caspase-1 inhibitor VI | SCBT - Santa Cruz Biotechnology
Caspase-1 inhibitor VI MF: C31H39FN4O9
MW: 630.66

Caspase-1 inhibitor VI

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 130ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Alternativa namn: Z-YVAD(OMe)-FMK
Ansökan Caspase-1 inhibitor VI is a cell-permeable, inhibitor of caspase-1, caspase-4, and caspase-5 activity
Renhet: ≥97%
Molekylvikt: 630.66
Molekylär formel: C31H39FN4O9
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).
loading

Caspase-1 inhibitor VI (Z-YVAD-FMK) is a cell-permeable, irreversible inhibitor of caspase-1, caspase-4, and caspase-5 activity. Caspase inhibitors play an important role in investigating biological processes. The caspase family of proteins function as key components of the apoptotic machinery and act to destroy specific target proteins which are critical to cellular longevity. Caspase-1, originally designated ICE (for IL-1 converting enzyme), is a member of the group of caspases with large prodomains. Active caspase-1, a (p20/p10)2 tetramer, is necessary and sufficient for cleavage of precursor IL-1 as well as for induction of apoptosis in some cell lines. Following use of the inhibitor, standard apoptosis assays can be used to examine treated cells for evidence of apoptosis.
Additional caspase-1 inhibitors available:
Caspase-1 inhibitor (sc-3069)
Caspase-1 Inhibitor II (sc-300323)
Caspase-1 Inhibitor IV (sc-300324)
Caspase-1 Inhibitor I (sc-358878)


Konferenser

1. Auerbuch, V. et al. 2009. PLoS Pathog. 5(12): e1000686. PMID: 19997504

2. Brenner, B., et al. 1998. Cell Death Differ. 5: 29-37. PMID: 10200443

3. Garcia-Calvo, M., et al. 1998. J. Biol. Chem. 273: 32608-32613. PMID: 9829999

4. Hilbi, H., et al. 1998. J. Biol. Chem. 273: 32895-32900. PMID: 9830039

5. Thornberry, N.A, et al. 1998. Science. 281: 1312-1316. PMID: 9721091

6. Schlegel, J., et al. 1996. J. Biol. Chem. 271: 1841-1844. PMID: 8567626

7. Enari, M., et al. 1995. Nature. 375: 78-81. PMID: 7536900

8. Walker, N.P., et al. 1994. Cell. 78: 343-352. PMID: 8044845

9. Thornberry, N.A., et al. 1992. Nature. 356: 768-774. PMID: 1574116

10. Pirnia, F. et al. 2006. Anticancer Res. 26(3A): 1765-1772. PMID: 16827105

Usage :
The carboxyl groups are OMe ester forms to enhance cell permeability. If purified enzyme is used, esterase should be added for the hydrolysis of the ester groups.

Prepare a 10mM stock solution of the caspase inhibitor in high quality DMSO.

Store solution aliquots at -20°C.
Appearance :
Lyophilized powder
Physical State :
Solid
Sequence :
Z-Tyr-Val-Ala-Asp(OMe)-FMK
Solubility :
Soluble in DMSO.
LAGRING :
Store at -20° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
SMILES :
CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)OCC2=CC=CC=C2

Download SDS (MSDS)

SAMPLE Certificate of Analysis (COA)

Caspase-1 inhibitor VI  SAMPLE Certificate of Analysis

Certificate of Analysis

SAMPLE Certificate of Analysis (COA)

Catalog Number:sc-3071
Lot Number:SAMPLE
Product Name:Caspase-1 inhibitor VI
Molecular Formula:C31H39FN4O9
Molecular Weight:630.66
TestSpecificationResults
AppearanceWhite powder
Identification (NMR)Consistent with structure
Purity (TLC)≥ 98%

Caspase-1 inhibitor VI  Produkt Citat

See how others have used Caspase-1 inhibitor VI. Click on the entry to view the PubMed entry .

Citations 1 to 10 of 34 total

PMID: 30692621 | SERPINB1-mediated checkpoint of inflammatory caspase activation. | Choi, YJ. et al. 2019. Nat. Immunol. 20: 276-287.

Citations 1 to 10 of 34 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 138ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 7ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;